Slingshot members are tracking this event:
FibroGen Publishes Roxadustat Phase 2 Data on Patients with Chronic Kidney Disease
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
Slingshot Insights Explained
Feb 16, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Phase 2 Data, Chronic Kidney Disease, Roxadustat